nach oben

Quality of Life Research

Erschienen in:

01.02.2014 | Brief Communication

Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmias

verfasst von: Derek H. Tang, Adrienne M. Gilligan, Klaus Romero

Erschienen in: Quality of Life Research | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Identify predictors of quality of life (QOL) in patients with any form of cardiac arrhythmia (CA).

Methods

Data from the Medical Panel Expenditure Survey were analyzed from 2004 to 2009. Patients aged ≥18 with any form of CA (identified via ICD-9-CM codes) were included. Primary outcomes included the physical and mental component scores (PCS and MCS) of the Short-Form 12 version 2 (SF-12) and EuroQoL-5D (EQ-5D) utility scores (US version). Patient demographics included insurance status, urban status, geographical region, federal poverty level, education, comorbidities, and disease-related risk factors of CA.

Results

Approximately 5,750,440 individuals had CA. Non-Hispanic Whites had the highest SF-12 MCS (mean 50.9; p < 0.001 across racial groups) and utility scores (mean 0.76; p < 0.001 across racial groups). Patients with both private and public insurance had significantly higher PCS (p = 0.001) and MCS (p < 0.001) in comparison with patients only covered by public insurance. Patients on antiarrhythmic agents had higher SF-12 MCS (51.4 vs. 48.4; p < 0.001) compared to individuals not on antiarrhythmic agents.

Conclusions

Significantly lower QOL existed in specific subpopulations (e.g., patients with only public health insurance, racial/ethnic minorities, and those not exposed to antiarrhythmic agents) within the CA population.

American Heart Association. (2012). http://www.heart.org/HEARTORG/. Accessed February 8, 2012.

The American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2009). Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119, e21–e181.CrossRef

Coyne, K. S., Paramore, C., Grandy, S., Mercder, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9, 348–356.PubMedCrossRef

Rohrbacker, N. J., Kleinman, N. L., White, S. A., March, J. L., & Reynolds, M. R. (2010). The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: Associated costs, absences, and objective productivity loss. Journal of Occupational and Environmental Medicine, 52, 383–391.PubMedCrossRef

Le Heuzey, J. Y., Paziaud, O., Piot, O., Said, M. A., Copie, X., Lavergne, T., et al. (2004). Cost of care distribution in atrial fibrillation patients: The COCAF study. American Heart Journal, 147, 121–126.PubMedCrossRef

Reynolds, M. R., Essebag, V., Zimetbaum, P., & Cohen, D. J. (2007). Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL registry. Journal of Cardiovascular Electrophysiology, 18, 628–633.PubMedCentralPubMedCrossRef

Dorian, P., Paquette, M., Newman, D., Green, M., Connolly, S. J., Talajic, M., et al. (2002). Quality of life improves with treatment in the Canadian trial of atrial fibrillation. American Heart Journal, 143, 984–990.PubMedCrossRef

Lönnerholm, S., Blomström, P., Nilsson, L., Oxelbark, S., Jideus, L., & Blomström-Lundqvist, C. (2000). Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation, 101, 2607–2611.PubMedCrossRef

Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42, 185–197.PubMedCrossRef

10.

Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., et al. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352, 1861–1872.PubMedCrossRef

11.

MEPS-HC Sample Design and Collection Process. (2012). Agency for Healthcare Research and Quality, Rockville, Md. http://www.meps.ahrq.gov/survey_comp/hc_data_collection.jsp. Accessed April 4, 2012.

12.

Chuang, L. H., & Kind, P. (2009). Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics, 27, 491–505.PubMedCrossRef

13.

Chisholm, M. A., Wells, B. G., Schwinghammer, T. L., Malone, P. M., Kolesar, J. M., & Rotschafer, J. C. (Eds.). (2007). Pharmacotherapy principles and practice. New York: McGraw Hill Medical.

14.

D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson Comorbidity Index with administrative databases. Journal of Clinical Epidemiology, 49, 1429–1433.PubMedCrossRef

15.

Schonlau, M. (2012). Stata software package, hotdeckvar.pkg, for hot deck imputation. 2006. Accessed April 4, 2012. Available from: http://www.schonlau.net/stata/.

16.

Lim, L. Y., & Fisher, J. D. (1999). Use of the 12-item Short-Form (SF-12) Health Survey in Australian heart and stroke population. Quality of Life Research, 8, 1–8.PubMedCrossRef

17.

Dorian, P., & Mangat, I. (2003). Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian trial of atrial fibrillation. Cardiac Electrophysiology Review, 7, 276–279.PubMedCrossRef

18.

Ware, J. E., Snow, K. K., Kosinski, M. A., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center.

19.

Ware, J. E., Bayliss, M. S., Rogers, W. H., Kosinski, M. A., & Tarlov, A. R. (1996). Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and Fee-for-Service Systems: Results from the Medical Outcomes Study. Journal of the American Medical Association, 276, 1039–1047.PubMedCrossRef

20.

Burdine, J. N., Felix, M., Abel, A. L., Wiltraut, C. J., & Musselman, Y. J. (2000). The SF-12 as a population health measure: An exploratory examination of potential for application. Health Services Research, 35, 885–903.PubMed

21.

Cheadle, A., Wagner, E., Koepsell, T., Kristal, A., & Patrick, D. (1992). Environmental indicators: A tool for evaluating community-based health promotion programs. American Journal of Preventive Medicine, 8, 345–350.PubMed

22.

Marmot, M. G., Bobak, M., Smith. G. D. (1995). Explanations for social inequalities in health. Society and Health. 46–92.

Titel: Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmias
verfasst von: Derek H. Tang
Adrienne M. Gilligan
Klaus Romero
Publikationsdatum: 01.02.2014
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 1/2014
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-013-0445-2

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Evaluation of a patient-reported continuity of care model for older adults

Exploratory and confirmatory factor analysis of the PROMIS pain quality item bank

Validation of the SF-36 in patients with endometriosis

Significance, truth and proof of p values: reminders about common misconceptions regarding null hypothesis significance testing

Difference in method of administration did not significantly impact item response: an IRT-based analysis from the Patient-Reported Outcomes Measurement Information System (PROMIS) initiative

Quality of life in head and neck cancer patients after tumor therapy and subsequent rehabilitation: an exploratory study